Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

Source Reference: Sammaritano LR, et al "2024 American College of Rheumatology (ACR) guideline for the screening, treatment, and management of lupus nephritis" Arthritis Rheumatol 2025; DOI: 10. ...

The 2024 ACR Guideline for LN provides evidence-based and expert guidance for the screening, treatment, and management of LN in adults and children. This is the ACR’s first LN Guideline since 2012 1.

References: 1) New ACR guideline summary provides guidance to screen, treat, and manage lupus nephritis. News release. American College of Rheumatology. November 18, 2024. Accessed November 22 ...

WASHINGTON — Early triple therapy may be the most effective strategy for lupus nephritis, according to the new 2024 American College of Rheumatology Guideline for the Screening, Treatment, and ...

Washington: During ACR Convergence 2024, the American College of Rheumatology (ACR) unveiled a summary of the 2024 Guideline for the Screening, Treatment, and Management of Lupus Nephritis. This marks ...

The recommendations focus on preserving kidney function, reducing chronic kidney disease-related morbidity and mortality, and minimizing medication-related toxicities. Screening and Diagnosis The ...

“We applaud ACR’s critical and timely guidelines to improve the management of lupus nephritis for this underserved patient population. They provide clear guidance for the importance of early diagnosis ...

New Guidelines Presented at ACR Convergence 2024 Recommend First-Line Therapy with LUPKYNIS® (voclosporin) as Part of a Triple Immunosuppressive LN Treatment Regimen Aurinia Pharmaceuticals Inc.

New Guidelines Presented at ACR Convergence 2024 Recommend First-Line Therapy with LUPKYNIS ® (voclosporin) as Part of a Triple Immunosuppressive LN Treatment Regimen ROCKVILLE, Md. & EDMONTON ...

Today at the American College of Rheumatology (ACR) Annual Meeting, Convergence 2024, the ACR released a summary of a new guideline for the screening, treatment and management of lupus nephritis ...